IMENOR 10 mg, scored tablet 10 tablets
Active ingredients: Methotrexate, Methotrexate sodium
Commercialized according to BDPMDispensing in France: Prescription only
Scored tablet10 tabletsorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- IMENOR 10 mg, comprimé sécable
- Pharmaceutical form
- comprimé sécable
- Route of administration
- orale
- Presentation description
- plaquette(s) PVC aluminium de 10 comprimé(s)
- Marketing authorisation holder
- ORION CORPORATION
- Reimbursement according to BDPM
- 100 %
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 15 Nov 2023
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
65787731CIP73026667CIP133400930266670Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| MÉTHOTREXATEcomprimé | 10 mg · un comprimé | FT |
| MÉTHOTREXATE DISODIQUEcomprimé | — | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.